Article Details

Loyal Announces $45 Million Series B Financing to Continue Development of First FDA ...

Retrieved on: 2024-03-28 20:07:14

Tags for this article:

Click the tags to see associated articles and topics

Loyal Announces $45 Million Series B Financing to Continue Development of First FDA .... View article details on hiswai:

Summary

The biotech company Loyal, focusing on extending the healthy lifespan of dogs, announced a $45 million funding round supporting FDA-approved longevity drugs development, aligning with transhumanist ideals of life extension to aging populations, including pets like beagles.

Article found on: yahopet.co.kr

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up